The project team developed MagnolAI, a sensor cloud with full-stack capabilities to continuously ingest, visualize, and transform a large amount of wearable sensor signals, in-clinic or at-home across the entire patient journey in connected clinical trials. Through MagnolAI, Lilly Digital Health is introducing connected devices, sensors, and measures to help manage trials – and as a result this allows for decentralized clinical trials in the modern era.

Hui Zhang, Executive Director, Digital Health Office, Eli Lilly and Company, Executive Director, Digital Health Office, Eli Lilly and Company